Kearns Thomas F Jr's Form 4 filing
Kyntra Bio, Inc. (KYNB) · filed Sep 17, 2021
- Accession no.
- 0001209191-21-056604
- Filed
- Sep 17, 2021
- Trade date
- Sep 15, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $151.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kearns Thomas F JrCIK 0001189184 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | Common Stock | SSaleDisposed | −13,100 | $11.58F1 | −$151,698 | 39,764 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares were sold in multiple transactions on the reported date with prices ranging from $11.46 to $11.615 resulting in a weighted average price of $11.5807. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction.
Referenced by the price of 1 transaction in Table I.